VASCULATA 2015

维管动物 2015

基本信息

  • 批准号:
    8984946
  • 负责人:
  • 金额:
    $ 1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-08-01 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Cardiovascular (CV) diseases such as hypertension, stroke and coronary heart disease are the leading cause of death in our nation and worldwide. Despite this, most students in the biomedical sciences lack substantive training in the field of cardiovascular biology. The scientific discipline of CV biology remains a relatively young field with a small critical mass of scientific experts trained in the discipline. The Vasculata research training conference series, which has been sponsored annually by the North American Vascular Biology Organization (NAVBO) since 2004, serves as a critical national resource to the scientific community by providing an invaluable forum for research training of aspiring biomedical scientists in CV biology and related fields. Vasculata 2015 will be held at the University of Virginia (UVA), and as with past Vasculatas, will provide a strong foundation of basic CV biology but with the novel theme of new paradigms for conducting translational and clinical research that lead to development of new and more effective drugs and therapeutic approaches for treating or preventing major CV diseases that are personalized for individual patients based on genetic, epigenetic, genomic, proteomic, bioinformatic, and systems engineering approaches. In addition, we will provide several workshops to build and enhance the technical skill set of trainees, and to provide professional career development advice and guidance, including assistance with their individual development plans (IDPs). Our goal is to inspire and enable graduate and undergraduate students, as well as post-doctoral fellows, clinical fellows, and young and more senior investigators from a variety of disciplines to conduct novel high impact CV research. The NIH funds being requested will be used entirely to support scholarships and travel funds for undergraduate and graduate students as well as post-doctoral fellows to attend the 4-day course. Additional funds for speakers, venue rental, refreshments, and other meeting costs will be provided by the UVA Robert M. Berne Cardiovascular Research Center, the Office of the President of UVA, and by private fundraising efforts including seeking support from Pharmaceutical, Medical Supply, and Medical Device Companies. As in the past, scholarships are given to trainees whose institution or departments do not have funding to support the travel of graduate students, postdoctoral fellows or undergraduate students. Particular attention will be given to enabling under-represented minority trainees to attend.
 描述(由适用提供):高血压,中风和冠心病等心血管(CV)疾病是我们国家和全球死亡的主要原因。尽管如此,生物医学科学中的大多数学生都缺乏心血管生物学领域的实质性培训。简历生物学的科学学科仍然是一个相对年轻的领域,其中有一小部分在学科中训练的科学专家。自2004年以来,北美血管生物学组织(NAVBO)每年赞助的Vasculata研究培训会议系列,通过为科学界提供了一个重要的国家资源,它为科学界提供了一个无价的论坛,用于研究对CV生物学及相关领域的有抱负的生物医学科学家的研究培训。 Vasculata 2015 will be held at the University of Virginia (UVA), and as with past Vasculatas, will provide a strong foundation of basic CV biology But with the novel theme of new paradigms for conducting translated and clinical research that lead to development of new and more effective drugs and therapeutic approaches for treating or preventing major CV diseases that are personalized for individual patients based on genetic, epigenetic, genomic,蛋白质组学,生物信息学和系统工程方法。此外,我们还将提供几个研讨会来建立和增强学员的技术技能,并提供职业职业发展建议和指导,包括有关其个人发展计划(IDP)的帮助。我们的目标是激发和使毕业生和本科生以及博士后研究员,临床研究员以及来自各个学科的年轻和更多的高级调查员,以进行新的高影响力CV研究。所要求的NIH资金将完全用于支持本科生和研究生的科学和旅行资金,以及博士后研究员参加为期4天的课程。 UVA Robert M. Berne心血管研究中心,UVA总裁办公室以及通过私人筹款工作,包括寻求药品,医疗供应和医疗设备公司的支持,将为演讲者,场地租赁,茶点和其他会议费用提供其他资金。与过去一样,奖学金是向机构或部门没有资金来支持研究生,博士后研究员或本科生的旅行的培训。将特别注意使代表性不足的少数族裔学员能够参加。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gary K Owens其他文献

Gary K Owens的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gary K Owens', 18)}}的其他基金

Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
  • 批准号:
    10652788
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
Role of Smooth Muscle Cell Insulin Resistance and Systemic Metabolic Dysfunction in Atherosclerosis Development and Late Stage Lesion Pathogenesis
平滑肌细胞胰岛素抵抗和全身代谢功能障碍在动脉粥样硬化发展和晚期病变发病机制中的作用
  • 批准号:
    10731723
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
Endothelial Cell to Mesenchymal Cell Transitions Play a Critical Biological Sex- and Aging-Dependent Role in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
内皮细胞向间充质细胞的转变在 Acta2 动脉粥样硬化病变保护性纤维帽的形成和维持中发挥着关键的生物性别和衰老依赖性作用
  • 批准号:
    10355596
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
Endothelial Cell to Mesenchymal Cell Transitions Play a Critical Biological Sex- and Aging-Dependent Role in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
内皮细胞向间充质细胞的转变在 Acta2 动脉粥样硬化病变保护性纤维帽的形成和维持中发挥着关键的生物性别和衰老依赖性作用
  • 批准号:
    10542427
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
Role of Metabolic Reprogramming in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
代谢重编程在 Acta2 动脉粥样硬化病变保护性纤维帽形成和维持中的作用
  • 批准号:
    10441555
  • 财政年份:
    2021
  • 资助金额:
    $ 1万
  • 项目类别:
Role of Metabolic Reprogramming in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
代谢重编程在 Acta2 动脉粥样硬化病变保护性纤维帽形成和维持中的作用
  • 批准号:
    10612042
  • 财政年份:
    2021
  • 资助金额:
    $ 1万
  • 项目类别:
Role of Metabolic Reprogramming in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
代谢重编程在 Acta2 动脉粥样硬化病变保护性纤维帽形成和维持中的作用
  • 批准号:
    10292012
  • 财政年份:
    2021
  • 资助金额:
    $ 1万
  • 项目类别:
IL1beta signaling in SMCpromotes beneficial changes in late stage atherosclerotic lesion pathogenesis
SMC 中的 IL1β 信号传导促进晚期动脉粥样硬化病变发病机制的有益变化
  • 批准号:
    10331329
  • 财政年份:
    2019
  • 资助金额:
    $ 1万
  • 项目类别:
Defining SMC phenotypes critical in late stage atherosclerosis pathogenesis
定义在晚期动脉粥样硬化发病机制中至关重要的 SMC 表型
  • 批准号:
    10084307
  • 财政年份:
    2018
  • 资助金额:
    $ 1万
  • 项目类别:
Oct4 and Klf4 regulate microvascular SMC-pericyte plasticity, angiogenesis, and metabolic dysfunction
Oct4 和 Klf4 调节微血管 SMC-周细胞可塑性、血管生成和代谢功能障碍
  • 批准号:
    9919376
  • 财政年份:
    2017
  • 资助金额:
    $ 1万
  • 项目类别:

相似国自然基金

平滑肌细胞MIA3激活BDNF参与神经调控动脉粥样硬化的机制研究
  • 批准号:
    82300513
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
Galectin-3/β-catenin通过NLRP3炎症小体调控血管平滑肌细胞泛凋亡抑制动脉粥样硬化作用和机制研究
  • 批准号:
    82370469
  • 批准年份:
    2023
  • 资助金额:
    47 万元
  • 项目类别:
    面上项目
有氧运动通过MeCP2乳酰化激活ZFP36转录促进TREM2hi巨噬细胞抗炎功能改善动脉粥样硬化的机制研究
  • 批准号:
    82372565
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
  • 批准号:
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
纳米氧化铁介导的磁热作用调节TRPV1信号通路抑制动脉粥样硬化的作用及其机制研究
  • 批准号:
    82300568
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Leadership and Administrative Core
领导和行政核心
  • 批准号:
    10730060
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
Impact of Per/Polyfluoroalkyl pollutants on vascular disease mechanisms
全氟烷基/多氟烷基污染物对血管疾病机制的影响
  • 批准号:
    10751239
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
Adherence to Clinical Practice Guidelines for Screening and Management of Pediatric High Blood Pressure within a Massachusetts Safety-Net Health Care System
遵守马萨诸塞州安全网医疗保健系统内儿童高血压筛查和管理的临床实践指南
  • 批准号:
    10464844
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
The role of racialized urban planning in shaping inequitable urban food environments and obesity disparities
种族化城市规划在塑造不公平的城市食品环境和肥胖差异中的作用
  • 批准号:
    10508915
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
Adherence to Clinical Practice Guidelines for Screening and Management of Pediatric High Blood Pressure within a Massachusetts Safety-Net Health Care System
遵守马萨诸塞州安全网医疗保健系统内儿童高血压筛查和管理的临床实践指南
  • 批准号:
    10700855
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了